Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide

Figure 1

Expression of class III β-tubulin, MAP2 and NSE in GBM cells. (A, B) ICC for class III β-tubulin, MAP2 and NSE in GBM cell lines and patient specimens. Staining intensity for NSE was stronger in the nuclei than in the cytoplasms. (C) Western blot for class III β-tubulin, MAP2 and NSE in GBM cells. Different isoforms of MAP2 were expressed in different GBM cells. GAPDH was the loading control. High Mw MAP2, high molecular MAP2; low Mw MAP2, low molecular MAP2. Scale bars: panel A = 20 μm, panel B = 50 μm.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us